These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7117681)

  • 1. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of a slow-release preparation of ketoprofen lysine in man.
    Borsa M; Tonon GC; Ronchi C; Zanolo G; Canali S
    Arzneimittelforschung; 1983; 33(10):1497-500. PubMed ID: 6418181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Biopharm Drug Dispos; 1984; 5(3):203-9. PubMed ID: 6487749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
    Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G
    Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary pharmacokinetics of orally administered ketoprofen in man.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):201-4. PubMed ID: 6519121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, interpatient comparison of plain and slow-release ketoprofen in osteoarthritis.
    Marcolongo R; Rubegni M; Provvedi D; Giordano N; Frati E; Bruni G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):377-81. PubMed ID: 6381334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail).
    Nievel JG; Havard CW; Mitchell P; Gudgeon A; Kaye CM
    Xenobiotica; 1987 Apr; 17(4):487-92. PubMed ID: 3604255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile of controlled release ketoprofen in elderly patients.
    Dennis MJ; French PC; Crome P; Babiker M; Shillingford J; Hopkins R
    Br J Clin Pharmacol; 1985 Dec; 20(6):567-73. PubMed ID: 4091989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The bioavailability of ketoprofen (Profenid) administered orally in combination with a gastric protector (aluminum phosphate, Phosphalugel)].
    Tamisier JN; Brazier JL; Ambert D; Bannier A
    Sem Hop; 1983 Dec; 59(46):3214-7. PubMed ID: 6318344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, crossover study of a sustained-release tablet of ketoprofen and normal ketoprofen capsules in the treatment of patients with osteoarthritis.
    Toft B; Christophersen J; Christensen N; Hesselsøe G; Mikkelsen S; Aaboe T; Mose K; Thorsager T; Jakobsen G
    Curr Med Res Opin; 1985; 9(10):708-12. PubMed ID: 3907991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.
    Upton RA; Williams RL; Guentert TW; Buskin JN; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(2):127-33. PubMed ID: 7262174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of a new ketoprofen formulation for once-daily oral administration.
    Roda A; Sabatini L; Mirasoli M; Baraldini M; Roda E
    Int J Pharm; 2002 Jul; 241(1):165-72. PubMed ID: 12086732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate.
    Brazier JL; Tamisier JN; Ambert D; Bannier A
    Eur J Clin Pharmacol; 1981 Mar; 19(4):305-7. PubMed ID: 7286034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal blood loss during administration of acetylsalicylic acid, ketoprofen and two new ketoprofen sustained-release compounds.
    Ranløv PJ; Nielsen SP; Bärenholdt O
    Scand J Rheumatol; 1983; 12(3):280-4. PubMed ID: 6604940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian changes in the pharmacokinetics of oral ketoprofen.
    Ollagnier M; Decousus H; Cherrah Y; Levi F; Mechkouri M; Queneau P; Reinberg A
    Clin Pharmacokinet; 1987 May; 12(5):367-78. PubMed ID: 3608343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioavailability of isosorbide-5-mononitrate from delayed-action formulations].
    Taylor T; Major RM; Leaf FC; Cook SC; Chasseaud LF; Darragh A; Lambe RF
    Arzneimittelforschung; 1984; 34(11):1584-7. PubMed ID: 6543135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of probenecid on ketoprofen kinetics.
    Upton RA; Williams RL; Buskin JN; Jones RM
    Clin Pharmacol Ther; 1982 Jun; 31(6):705-12. PubMed ID: 7075118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis.
    Christophidis N; Rotstein A; Louis WJ
    Clin Exp Pharmacol Physiol; 1986 Jul; 13(7):555-61. PubMed ID: 3791708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.